U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07617350) titled 'Study of the Subdermal Implant "Ultracol"' on Oct. 23, 2024.
Brief Summary: Study of the effectiveness of the medical device "Intradermal implant, sterile ULTRACOL based on polydioxanone (ULTRA V Co., Ltd., Korea) in the correction of skin contour defects.
Study Start Date: July 16, 2024
Study Type: INTERVENTIONAL
Condition:
Skin Aging
Facial Wrinkles
Senile Skin Atrophy
Lipodystrophy
Facial Lipoatrophy
Nasolabial Folds
Intervention:
DEVICE: Administration of the prepared solution - 1 time Post injection observation - 30, 60, 160 days from the date of the first injection.
Lyophilized intradermal implant based on polydioxanone ...